Policy Brief
Published on 14 Nov 2024
Identifying and overcoming challenges in the EMA’s qualification of novel methodologies: a two-year review
in Drugs Outcomes Research and Policies
- 144 views
Policy Brief
Published on 14 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 14 Nov 2024
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 14 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 13 Nov 2024
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 13 Nov 2024
in Ethnopharmacology
Original Research
Accepted on 13 Nov 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 13 Nov 2024
in Neuropharmacology
Original Research
Accepted on 13 Nov 2024
in Translational Pharmacology
Review
Accepted on 13 Nov 2024
in Integrative and Regenerative Pharmacology
Original Research
Accepted on 13 Nov 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 13 Nov 2024
in Cardiovascular and Smooth Muscle Pharmacology
Systematic Review
Accepted on 13 Nov 2024
in Ethnopharmacology
Original Research
Published on 13 Nov 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Nov 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 13 Nov 2024
in Integrative and Regenerative Pharmacology
Review
Published on 13 Nov 2024
in Experimental Pharmacology and Drug Discovery